The use of d‐lysergic acid diethylamide, LSD, as a reference standard for the evaluation of psychopathologic symptoms was tested. A group of healthy male volunteers took weekly doses of LSD in order to become familiar with the temporary mental changes induced by the drug.
The subjects were able to identify three dose levels of LSD and to differentiate LSD from placebo and other drugs. A standard curve of the responses to LSD could be constructed for these subjects.
A combination of reserpine plus iproniazid was found not to produce LSD‐like psychopathologic symptoms. The addition of reserpine and iproniazid to LSD did not change the degree or intensity of LSD‐induced psychopathologic symptoms in man.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.